Clinical Genomics Licenses Biomarkers from Garvan Institute
September 27, 2010
Clinical Genomics Licenses Biomarkers from Garvan Institute
The Sydney, Australia-based firm obtained worldwide, exclusive rights to Garvan's cancer-associated methylation DNA biomarkers for the diagnosis and/or treatment of colorectal cancer.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.